Respiratory

This Week in Managed Care: January 8, 2021

January 8th 2021, 2:23pm

Video

This week, the top managed care news included FDA advising against changes to vaccine dose schedules; drop in mammography screenings during the first months of the pandemic; first anti-TIGIT therapy granted Breakthrough Therapy designation by the FDA.

What We're Reading: FDA Stands Fast on COVID-19 Vaccine Dosing; Haven Dissolves; Moderna Boosts Dose Supply

January 5th 2021, 3:30pm

Article

The FDA warns against making any changes to the authorized dosing schedules of coronavirus disease 2019 (COVID-19) vaccines; joint health care venture, Haven, dissolves; Moderna announced it will increase production of its vaccine by 100 million doses for 2021.

A Timeline of COVID-19 Developments in 2020

January 1st 2021, 10:00pm

Article

Coronavirus disease 2019 (COVID-19) dominated 2020. This is a look back at how the pandemic evolved and progressed through the year, which closed with the arrival of vaccines, but also continued challenges.

Dr Megan Althoff on How, Why the GINA, ERS/ATS Guidelines Differ

December 30th 2020, 2:00pm

Video

One guideline focuses on managing severe asthma and the other begins with recommendations for mild intermittent asthma before increasing based on disease severity, noted Megan Althoff, MD, PhD, University of Colorado.

Top 5 Most-Read Respiratory Stories of 2020

December 29th 2020, 3:00pm

Article

The top 5 most-read respiratory stories of 2020 on AJMC.com largely focused on the treatment options and risks associated with idiopathic pulmonary fibrosis (IPF) as well as how mental health and asthma are related.

Dr Nicola Hanania: Exacerbation Improvement Is an Important Indicator of Patient Response to Biologics

December 23rd 2020, 3:00pm

Video

When evaluating a patient’s response to a biologic for asthma, factors to consider include patient preference, safety, and symptoms, explained Nicola Hanania, MD, MS, pulmonary critical care physician and director, Airway Clinical Research Center, Baylor College of Medicine, Houston, Texas.

What We’re Reading: US Buys More Pfizer Vaccine; Walmart Sued Over Opioid Crisis; 2020's Deadly Toll

December 23rd 2020, 2:50pm

Article

The Trump administration buys 100 million more doses of Pfizer's coronavirus disease 2019 (COVID-19) vaccine; the Department of Justice files a suit accusing Walmart of fueling the opioid crisis; 2020 set to become deadliest year in US history.

Top 5 Most-Read COVID-19 News of 2020

December 21st 2020, 10:43pm

Article

A look at some of our most-read news coverage of the coronavirus disease 2019 (COVID-19) pandemic.

FDA Panel Backs Moderna COVID-19 Vaccine; EUA Expected Next

December 17th 2020, 10:00pm

Article

After a daylong meeting, an FDA advisory panel agreed that the second vaccine in the United States to prevent coronavirus disease 2019 (COVID-19) should be put forward for use.

COVID-19 and Health Disparities: An Opportunity to Refocus Resources?

December 14th 2020, 5:00pm

Article

Stark realities exposed by the pandemic have led some to advocate for redirecting resources to have the most impact on vulnerable populations.